feed,title,long_url,short_url
🔐MarketWatch,"Reata’s new rare-disease drug will cost $370,000 per year",http://www.marketwatch.com/news/story/reatas-new-rare-disease-drug-cost/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D71A7%2D742DFFA8E256%7D&siteid=rss,https://da.gd/214qW
🔐MarketWatch,U.S. oil futures mark highest finish in nearly 2 weeks,http://www.marketwatch.com/news/story/us-oil-futures-mark-highest/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D71A7%2D734DCC1594F7%7D&siteid=rss,https://da.gd/M5lk
🔐MarketWatch,Sarepta’s stock still up after Tuesday’s announcement that its Duchenne drug candidate won’t require a FDA AdCom meeting,http://www.marketwatch.com/news/story/sareptas-stock-still-up-after/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D71A7%2D6EB68D86711B%7D&siteid=rss,https://da.gd/hsUsq4
